New cancer clinical trial: Phase I/Ib Trial of Single Agent PBF-999 in Solid Tumour Advanced Cancer

Published on: December 25, 2018 at 12:00PM
Condition:   Cancer
Intervention:   Drug: PBF-999
Sponsors:   Palobiofarma SL;   Vall d'Hebron institute of oncology (VHIO), Catalan institute of oncology (Hospitalet) (ICO)
Recruiting
http://bit.ly/2RogdC4